Hemoglobinopathy Market, By Test Type (Routine Red Blood Cell (RBC) count, Genetic Testing, Hemoglobin by high performance liquid chromatography, Hemoglobin isoelectric focusing ( Hb IEF), Hemoglobin electrophoresis (Hb ELP), Hemoglobin solubility test),

Hemoglobinopathy Market, By Test Type (Routine Red Blood Cell (RBC) count, Genetic Testing, Hemoglobin by high performance liquid chromatography, Hemoglobin isoelectric focusing ( Hb IEF), Hemoglobin electrophoresis (Hb ELP), Hemoglobin solubility test), By Indication (Sickle Cell Disease, Beta Thalassemia, Alpha Thalassemia), By End User (Hospitals, Diagnostic Laboratories, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body. Hemoglobinopathy disorder are inherited and are passed on from one generation to another. It is further classified into two categories – 1. Thalassemia Syndrome 2. Structural Hemoglobin Variants. Thalassemia syndrome includes disorder related to synthesis defect. The synthesis defect of alpha globin gives rise to alpha thalassemia and defect in beta globin give rise to beta thalassemia. The structural hemoglobin variants occur due to alteration of alpha and beta chains that causes defect in structure.

Restraints of the Global Hemoglobinopathy Market

High costs, and difficulties associated with diagnosis of hemoglobinopathies such as lack of proper knowledge, and lack of skilled professionals is expected to restrain growth of the market up to certain extent.

Key features of the study:

This report provides in-depth analysis of the global hemoglobinopathy market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global hemoglobinopathy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Abbott Diagnostics, Bio-Rad Laboratories, Inc., Danaher Corp., ReachBio Research Labs, Mindray Medical International Ltd., Nexcelom Bioscience LLC, Nihon Kohden Europe Ltd., PerkinElmer Inc., Siemens Healthineers, and Sysmex Europe GmbH

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global hemoglobinopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Hemoglobinopathy Market, By Test Type:

Routine Red Blood Cell (RBC) count

Genetic Testing

Hemoglobin by high performance liquid chromatography

Hemoglobin isoelectric focusing ( Hb IEF)

Hemoglobin electrophoresis (Hb ELP)

Hemoglobin solubility test

Global Hemoglobinopathy Market, By Indication:

Sickle Cell Disease

Beta Thalassemia

Alpha Thalassemia

Global Hemoglobinopathy Market, By End User:

Hospitals

Diagnostic Laboratories

Clinics

Global Hemoglobinopathy Market, By Geography:

North America

By Test Type

Routine Red Blood Cell (RBC) count

Genetic Testing

Hemoglobin by high performance liquid chromatography

Hemoglobin isoelectric focusing ( Hb IEF)

Hemoglobin electrophoresis (Hb ELP)

Hemoglobin solubility test

By Indication

Sickle Cell Disease

Beta Thalassemia

Alpha Thalassemia

By End User

Hospitals

Diagnostic Laboratories

Clinics

By Country:

U.S.

Canada

Europe

By Test Type

Routine Red Blood Cell (RBC) count

Genetic Testing

Hemoglobin by high performance liquid chromatography

Hemoglobin isoelectric focusing ( Hb IEF)

Hemoglobin electrophoresis (Hb ELP)

Hemoglobin solubility test

By Indication

Sickle Cell Disease

Beta Thalassemia

Alpha Thalassemia

By End User

Hospitals

Diagnostic Laboratories

Clinics

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Test Type

Routine Red Blood Cell (RBC) count

Genetic Testing

Hemoglobin by high performance liquid chromatography

Hemoglobin isoelectric focusing ( Hb IEF)

Hemoglobin electrophoresis (Hb ELP)

Hemoglobin solubility test

By Indication

Sickle Cell Disease

Beta Thalassemia

Alpha Thalassemia

By End User

Hospitals

Diagnostic Laboratories

Clinics

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Test Type

Routine Red Blood Cell (RBC) count

Genetic Testing

Hemoglobin by high performance liquid chromatography

Hemoglobin isoelectric focusing ( Hb IEF)

Hemoglobin electrophoresis (Hb ELP)

Hemoglobin solubility test

By Indication

Sickle Cell Disease

Beta Thalassemia

Alpha Thalassemia

By End User

Hospitals

Diagnostic Laboratories

Clinics

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Test Type

Routine Red Blood Cell (RBC) count

Genetic Testing

Hemoglobin by high performance liquid chromatography

Hemoglobin isoelectric focusing ( Hb IEF)

Hemoglobin electrophoresis (Hb ELP)

Hemoglobin solubility test

By Indication

Sickle Cell Disease

Beta Thalassemia

Alpha Thalassemia

By End User

Hospitals

Diagnostic Laboratories

Clinics

By Country:

GCC

Israel

Rest of Middle East

Africa

By Test Type

Routine Red Blood Cell (RBC) count

Genetic Testing

Hemoglobin by high performance liquid chromatography

Hemoglobin isoelectric focusing ( Hb IEF)

Hemoglobin electrophoresis (Hb ELP)

Hemoglobin solubility test

By Indication

Sickle Cell Disease

Beta Thalassemia

Alpha Thalassemia

By End User

Hospitals

Diagnostic Laboratories

Clinics

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Abbott Diagnostics *

Company Overview

Test Portfolio

Financial Performance

Key Strategies

Recent Developments

Bio-Rad Laboratories, Inc.

Danaher Corp.

ReachBio Research Labs

Mindray Medical International Ltd.

Nexcelom Bioscience LLC

Nihon Kohden Europe Ltd.

PerkinElmer Inc.

Siemens Healthineers

Sysmex Europe GmbH

“*” marked represents similar segmentation in other categories in the respective section.


Table of Contents
Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Test Type
Market Snippet, By Indication
Market Snippet, By End User
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
Global Hemoglobinopathy Market, By Test Type, 2019 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
Routine Red Blood Cell (RBC) count
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Genet~ic Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Hemoglobin by high performance liquid chromatography
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Hemoglobin isoelectric focusing ( Hb IEF)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Hemoglobin electrophoresis (Hb ELP)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Hemoglobin solubility test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Global Hemoglobinopathy Market, By Indications, 2019 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
Sickle Cell Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Beta Thalassemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Alpha Thalassemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Global Hemoglobinopathy Market, By End User, 2019 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Global Hemoglobinopathy Market, By Regions, 2019 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
North Africa
Central Africa
South Africa
Competitive Landscape
Company Profiles
Abbott Diagnostics
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
Bio-Rad Laboratories, Inc.
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
Danaher Corp.
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
ReachBio Research Labs
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
Mindray Medical International Ltd.
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
Nexcelom Bioscience LLC
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
Nihon Kohden Europe Ltd.
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
PerkinElmer Inc.
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
Siemens Healthineers
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
Sysmex Europe GmbH
Company Overview
Test Portfolio
Key Developments
Financial Performance
Strategies
Section
References
Research Methodology
About us and Sales Contact
*Browse 31 market data tables and 27 figures on “Hemoglobinopathy Market – Global forecast to 2027.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook